FDA approves insulin app for type 2 diabetes

The iSage Rx app, developed by Amalgam Rx, has been approved by the US Food and Drug Administration (FDA). It is a prescription-only mobile app for the automated titration of all brands of basal insulin, including Lantus, Levemir, Toujeo, Tresiba and Basaglar.

iSage allows physicians to choose from multiple clinically-validated basal insulin algorithms and tailor the algorithms to the specific needs of their type 2 diabetes patients. In addition to basal dosing support, the app also includes behavioral, clinical and educational support to help patients overcome the obstacles associated with the self-administration of insulin injection therapy.

Read more